Effectiveness of Adjuvant Chemo- and Radiotherapy in Thymic Carcinoma Stage II: A Systematic Review and Meta-Analysis
Background Thymic carcinoma is a rare tumor arising from the epithelial thymic tissue, yet among mediastinal tumors, it is the most common malignant entity. Thymic carcinoma often causes no symptoms and is incidentally discovered. Adjuvant radiotherapy is recommended, particularly in cases of incomp...
Saved in:
| Main Authors: | Ahmad Nazzal MD, Josef Yayan MD, PhD, Christian Biancosino MD, PD, Seyed Vahid Tabatabaei MD, Khosro Hekmat MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-10-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748241292781 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Phase II Clinical Trial of Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced High-Grade Thymic Tumors
by: Ning Xu, MD, et al.
Published: (2025-06-01) -
Inadequate Lymph Node Yield: An Inadequate Indication for Adjuvant Chemotherapy in Stage II Colon Cancer
by: Alan Zambeli-Ljepović, MD, MHS, et al.
Published: (2023-12-01) -
Yttrium-90 Radioembolization for Hepatic Metastases Secondary to Thymic Malignancies: A Case Report
by: Gavin Yuan, BA, et al.
Published: (2025-05-01) -
CD5 Immunoreactivity Is Associated With Longer Overall Survival in Thymic Carcinoma: A Brief Report
by: Julia R. Naso, MD, PhD, et al.
Published: (2025-05-01) -
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L
by: Hideyuki Harada, MD, PhD, et al.
Published: (2025-06-01)